ArticleFrontiers in public health2022
Green effects of research and development on industrial waste reduction during the production phase: Evidence from China and policy implications.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mitigating environmental public health risks via artificial intelligence: mechanisms and boundary conditions.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Maintaining public health requires a clean environment; however, some industrial wastes can damage the water, atmosphere, and living environment seriously. To promote green development, policy makers in China have developed and implemented strict environmental regulations to limit the pollutant emissions and improve the environmental quality. Industrial producers implement research and development (R&D) activities to gain more profits in competitive markets. A comprehensive understanding of the green effects of R&D on different industrial wastes could provide important policy recommendations, especially regarding the coordination of innovative and green developments. In this study, the author empirically analyzed the influence of R&D input, including the intramural expenditure on R&D and full-time equivalent of R&D personnel, on industrial wastes, including the discharge of chemical oxygen demand (COD) and ammonia nitrogen, emission of sulfur dioxide, nitrogen oxides, and particulate matter, and generation of common industrial solid and hazardous wastes, based on the data from Chinese industrial sectors for 2016-2020. The main findings of empirical analyses were robust and indicated that R&D activities significantly reduced the emissions of all three industrial waste gases and decreased the discharge of COD; however, in the case of China, the partial effects on the discharge of ammonia nitrogen and the industrial solid wastes were not statistically significant. The green effects of R&D on different industrial wastes may vary and generally depend on environmental regulations, with various limitations. The most viable policy recommendations indicate that by expanding and initiating the green effect of R&D on different industrial wastes, innovative and green developments are more likely to be achieved in a coordinated manner. Additionally, this can also support special R&D activities, with the added benefit of actively developing cleaner technology to treat pollutant emissions. Development, while maintaining a clean environment to ensure public health, could be more sustainable if innovative activities reduce the production of industrial wastes. This study analyzes the green effects of R&D on industrial waste and can serve as a viable framework for future studies on sustainable development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.